Brief: Oncosil Medical Says Loss For Half-Year Attributable A$5.7 Million
28/02/2023 07:49
Feb 28 (Reuters) - Oncosil Medical Ltd OSL.AX :
* LOSS FOR HALF-YEAR ATTRIBUTABLE A$5.7 MILLION
Source text for Eikon: ID:nASX8tVQw8
Further company coverage: OSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval